Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists: an overview.

L Hansson1

  • 1Department of Medicine, University of Gothenburg, Ostra Hospital, Sweden.

American Heart Journal
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Calcium antagonists effectively lower blood pressure by reducing calcium influx, leading to decreased vascular resistance. Newer dihydropyridine calcium antagonists are recommended as a first-line hypertension treatment due to their efficacy and favorable safety profile.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Lancet (London, England)·2000
Same author

Operations for extrahepatic bile duct cancers: are the results really improving?

The European journal of surgery = Acta chirurgica·2000
Same author

Blood pressure @ Internet-www.bloodpressure.nu.

Blood pressure·2000
Same author

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

Blood pressure·2000
Same author

Endothelial dysfunction--a challenge for hypertension research.

Blood pressure·2000
Same author

Introduction: the role of combination therapy in modern antihypertensive therapy.

Journal of cardiovascular pharmacology·2000
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
See all related articles

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Calcium antagonists modulate calcium ion influx via calcium channels.
  • This action impacts myocardial contractility and vascular smooth muscle tone, consequently lowering blood pressure.

Purpose of the Study:

  • To review the mechanisms and clinical applications of calcium antagonists in hypertension management.
  • To highlight the advantages of newer dihydropyridine calcium antagonists.

Main Methods:

  • Review of the pharmacological actions of calcium antagonists.
  • Analysis of molecular structures and binding characteristics of different calcium antagonist classes.
  • Evaluation of clinical outcomes and safety profiles of specific agents like nicardipine.

Main Results:

Related Experiment Videos

  • Calcium antagonists reduce blood pressure by decreasing myocardial contractility and/or vascular resistance.
  • Dihydropyridines, particularly nicardipine, exhibit high vascular selectivity and effectively lower blood pressure.
  • These agents do not adversely affect glucose or lipid metabolism and are well-tolerated.

Conclusions:

  • Calcium antagonists are effective in managing hypertension.
  • Newer dihydropyridine calcium antagonists offer a favorable risk-benefit profile for first-line therapy.
  • International guidelines recommend calcium antagonists for initial hypertension treatment.